27R.F RaySearch Laboratories AB (publ)

Healthcare Health Care Technology Frankfurt Exchange
17.26 EUR
Close of Nov 12, 2026
14.73 20.96
Market cap
EUR 514M
P/E
28.1x
P/B
7.06x
ROE
22.5%
Dividend yield
2.35%
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.

Is 27R.F undervalued?

Graham number
Price17.26
Graham value5.81
Premium196.8%

27R.F trades 196.8% above its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

RaySearch Laboratories AB (publ) fundamental analysis

No fundamental analysis for RaySearch Laboratories AB (publ) yet.

RaySearch Laboratories AB (publ) stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About RaySearch Laboratories AB (publ)

RaySearch Laboratories AB (publ), a medical technology company, provides software solutions for cancer treatment worldwide. It offers RayStation, a treatment planning system for cancer centers; RayCare, an oncology information system for clinics; RayIntelligence, cloud-based oncology analytics system that cancer centers can use to gather, structure and analyze data; and RayCommand, a treatment control system designed to link the treatment machine and the treatment planning a…

Full company profile